Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome

Chinese Journal of Cancer

Volumn 29, Issue 8, 2010, Pages 721-728

  Cao, Su Mei ^a   Yu, Jie Kai ^b   Chen, Qiu Yan ^a   Li, Ning Wei ^a   Xiang, Yan Qun ^a   Qian, Chao Nan ^a   Hu, Xun ^b   Zhang, Chang Qing ^a   Xie, Dan ^a   Guo, Xiang ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diagnosis; Mass spectrometry; Nasopharyngeal neoplasms; Neural networks (computer); Proteomic; Surface enhanced laser desorption ionization

Indexed keywords

PROTEOME;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOINFORMATICS; BLOOD SAMPLING; CANCER STAGING; CATION EXCHANGE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TUMOR CLASSIFICATION;

EID: 79955863262     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10037     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
2. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival [J]. J Clin Oncol, 2003, 21(4): 631-637.
3. Chow E, Payne D, O'Sullivan B, et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? [J]. Radiother Oncol, 2002, 63(3): 269-274.
4. Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China [J]. Int J Radiat Oncol Biol Phys, 1994, 30(5): 1037-1042.
5. Zeng Y, Zhong JM, Li LY, et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China [J]. Intervirology, 1983, 20(4): 190-194.
6. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China [J]. Int J Cancer, 1982, 29(2): 139-141.
7. Merchant M, Weinberger SR. Recent advancements in surfaceenhanced laser desorption/ionization-time of flight-mass spectrometry [J]. Electrophoresis, 2000, 21(6): 1164-1177.
8. Kuwata H, Yip TT, Yip CL, et al. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry [J]. Biochem Biophys Res Commun, 1998, 245(3): 764-773.
9. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer [J]. Lancet, 2002, 359 (9306): 572-577.
10. Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer [J]. Clin Chem, 2002, 48(8): 1296-1304.
11. Al-Ruwaili JA, Larkin SE, Zeidan BA, et al. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis [J]. Cancer Genomics Proteomics, 2010, 7(2): 93-103.
12. Saito Y, Oba N, Nishinakagawa S, et al. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-in visible hepatocellular carcinoma in patient with liver cirrhosis [J]. Oncol Rep, 2010, 23(5): 1325-1330.
13. Cho WC, Yip TT, Yip C, et al. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling [J]. Clin Cancer Res, 2004, 10(1 Pt 1): 43-52.
14. Cho WC, Yip TT, Ngan RK, et al. ProteinChip array profiling for identification of disease-and chemotherapy-associated biomarkers of nasopharyngeal carcinoma [J]. Clin Chem, 2007, 53 (2): 241-250.
15. Romualdi C, Campanaro S, Campagna D, et al. Pattern recognition in gene expression profiling using DNA array: a comparative study of different statistical methods applied to cancer classification [J]. Hum Mol Genet, 2003, 12(8): 823-836.
16. Ball G, Mian S, Holding F, et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers [J]. Bioinformatics, 2002, 18(3): 395-404.
17. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells [J]. Proc Natl Acad Sci U S A, 1966, 56(6): 1699-1704.
18. Tsao SY, He Y, Cheng PM, et al. Epstein-Barr virus in oropharyngeal and nasopharyngeal secretions of patients with nasopharyngeal carcinoma and control subjects [J]. Intervirology, 1991, 32(4): 209-215.
19. Uen WC, Luka J, Pearson GR. Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus [J]. Int J Cancer, 1988, 41(4): 479-482.
20. Seigneurin JM, Lavoue MF, Genoulaz O, et al. Antibody response against the Epstein-Barr virus-coded nuclear antigen 2 (EBNA2) in different groups of individuals [J]. Int J Cancer, 1987, 40(3): 349-353.
21. Rooney CM, Rowe DT, Ragot T, et al. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle [J]. J Virol, 1989, 63(7): 3109-3116.
22. Cheng YC, Chen JY, Glaser R, et al. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma [J]. Proc Natl Acad Sci U S A, 1980, 77(10): 6162-6165.
23. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma [J]. Cancer Res, 1999, 59(6): 1188-1191.
24. Chan KH, Gu YL, Ng F, et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma [J]. Int J Cancer, 2003, 105(5): 706-709.
25. Wei JT, Zhang Z, Barnhill SD, et al. Understanding artificial neural networks and exploring their potential applications for the practicing urologist [R]. Urology, 1998, 52(2): 161-172.
26. Tafeit E, Reibnegger G. Artificial neural networks in laboratory medicine and medical outcome prediction [R]. Clin Chem Lab Med, 1999, 37(9): 845-853.